[Cystic fibrosis in 2008]
1Service de médecine interne, service adulte du centre de référence national de lyon, centre de ressource et de compétences de la mucoviscidose, centre hospitalier Lyon-Sud, 69495 Pierre-Bénite cedex, France. isabelle.durieu@chu-lyon.fr
La Revue De Medecine Interne
|February 23, 2008
Summary
Cystic Fibrosis (CF) care has advanced significantly, increasing life expectancy and understanding of the CFTR gene. Future treatments aim to correct the underlying genetic defect for this rare disease.
Area of Science:
- Genetics and Molecular Biology: Focus on the CFTR gene and protein structure/function.
- Epidemiology: Analysis of disease prevalence, patient demographics, and survival rates.
- Medical Research: Exploration of pathological mechanisms and disease progression in cystic fibrosis.
Context:
- Cystic Fibrosis (CF) is a rare genetic disorder with evolving management strategies.
- Increased life expectancy in CF patients necessitates a greater focus on adult care and long-term complications.
- Neonatal screening implemented in France aims to improve early diagnosis and outcomes.
Purpose:
- To provide a comprehensive overview of current knowledge on cystic fibrosis (CF).
- To highlight advancements in understanding the CFTR gene and its role in CF.
- To discuss the evolving organization of CF healthcare and emerging therapeutic avenues.
Summary:
- Life expectancy for CF patients has significantly increased, with a growing adult population.
- Lung disease remains the primary cause of morbidity and mortality, alongside other organ system involvements.
- Current treatments are symptomatic, focusing on pulmonary and nutritional support.
Impact:
- Improved understanding of CFTR facilitates the development of novel, targeted therapies.
- Enhanced healthcare organization in specialized CF centers improves patient management.
- Future treatments aim to address the root cause of CF through gene therapy or pharmacological modulation.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...